{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:12:07Z","timestamp":1791331927376,"version":"4.3.1"},"reference-count":163,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2014.00125","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T12:47:02Z","timestamp":1401194822000},"source":"Crossref","is-referenced-by-count":36,"title":["Perspectives of Differentiation Therapies of Acute Myeloid Leukemia: The Search for the Molecular Basis of Patients\u00e2\u20ac\u2122 Variable Responses to 1,25-Dihydroxyvitamin D and Vitamin D Analogs"],"prefix":"10.3389","volume":"4","author":[{"given":"Aleksandra","family":"Marchwicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00c5\u201agorzata","family":"Cebrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetha","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5\u0081ukasz","family":"\u00c5\u0161nie\u00c5\u00bcewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Marcinkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature03095","article-title":"Targeted cancer therapy","volume":"432","author":"Sawyers","year":"2004","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood.V89.6.1845","article-title":"Apoptosis and the dilemma of cancer chemotherapy","volume":"89","author":"Hannun","year":"1997","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc989","article-title":"Disruption of differentiation in human cancer: AML shows the way","volume":"3","author":"Tenen","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B5","first-page":"1981","article-title":"Cell differentiation and bypassing of genetic defects in the suppression of malignancy","volume":"47","author":"Sachs","year":"1987","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1073\/pnas.77.5.2936","article-title":"Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid","volume":"77","author":"Breitman","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1182\/blood.V99.3.759","article-title":"Acute promyelocytic leukemia: evolving therapeutic strategies","volume":"99","author":"Tallman","year":"2002","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(91)90113-D","article-title":"The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR","volume":"66","author":"de Th\u00c3\u00a9","year":"1991","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0092-8674(91)90112-C","article-title":"Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML","volume":"66","author":"Kakizuka","year":"1991","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1038\/sj.leu.2402720","article-title":"Variations on a theme: the alternate translocations in APL","volume":"16","author":"Redner","year":"2002","journal-title":"Leukemia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/sj.onc.1209216","article-title":"Leukemia with distinct phenotypes in transgenic mice expressing PML\/RAR alpha, PLZF\/RAR alpha or NPM\/RAR alpha","volume":"25","author":"Rego","year":"2006","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/MOH.0b013e3283007edf","article-title":"Retinoic acid receptors, hematopoiesis and leukemogenesis","volume":"15","author":"Collins","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1351\/pac200375111709","article-title":"Functions of RARs and RXRs in vivo: genetic dissection of the retinoid signaling pathway","volume":"75","author":"Mark","year":"2003","journal-title":"Pure Appl Chem"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood.V80.8.1885.1885","article-title":"Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity","volume":"80","author":"Robertson","year":"1992","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1182\/blood-2005-03-0860","article-title":"Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation","volume":"106","author":"Iwasaki","year":"2005","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1182\/blood-2005-07-3068","article-title":"ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression","volume":"107","author":"Mueller","year":"2006","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.1093\/emboj\/cdg556","article-title":"C\/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells","volume":"22","author":"Duprez","year":"2003","journal-title":"EMBO J"},{"key":"B19","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/blood.V90.7.2591","article-title":"A novel, myeloid transcription factor, C\/EBPepsilon, is upregulated during granulocytic, but not monocytic, differentiation","volume":"90","author":"Morosetti","year":"1997","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nrm2277","article-title":"Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies","volume":"8","author":"Bernardi","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood.V82.6.1858.1858","article-title":"PML protein expression in hematopoietic and acute promyelocytic leukemia cells","volume":"82","author":"Daniel","year":"1993","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"a000661","DOI":"10.1101\/cshperspect.a000661","article-title":"PML nuclear bodies","volume":"2","author":"Lallemand-Breitenbach","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ceb.2011.03.011","article-title":"The nuclear bodies inside out: PML conquers the cytoplasm","volume":"23","author":"Carracedo","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/sj.bjc.6606095","article-title":"Genome-wide functions of PML-RAR\u00ce\u00b1 in acute promyelocytic leukaemia","volume":"104","author":"Saeed","year":"2011","journal-title":"Br J Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/intimm\/dxr004","article-title":"PML is a key component for the differentiation of myeloid progenitor cells to macrophages","volume":"23","author":"Khalfin-Rabinovich","year":"2011","journal-title":"Int Immunol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood.V88.8.2826.bloodjournal8882826","article-title":"The PML\/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells","volume":"88","author":"Raelson","year":"1996","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V93.10.3167.410k44_3167_3215","article-title":"Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia","volume":"93","author":"Melnick","year":"1999","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1521-6926(03)00062-8","article-title":"Molecular pathogenesis of acute promyelocytic leukaemia and APL variants","volume":"16","author":"Sirulnik","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrc2943","article-title":"Acute promyelocytic leukaemia: novel insights into the mechanisms of cure","volume":"10","author":"de Th\u00c3\u00a9","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s12185-013-1354-4","article-title":"Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia","volume":"97","author":"Tomita","year":"2013","journal-title":"Int J Hematol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/shem.2001.20865","article-title":"Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models","volume":"38","author":"Rego","year":"2001","journal-title":"Semin Hematol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/cr.2008.58","article-title":"New insights into the role of PML in tumour suppression","volume":"18","author":"Salomoni","year":"2008","journal-title":"Cell Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1182\/blood-2003-07-2200","article-title":"Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia","volume":"103","author":"Gurrieri","year":"2004","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"14465","DOI":"10.1074\/jbc.M600457200","article-title":"Cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor-alpha","volume":"281","author":"Bellodi","year":"2006","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cyto.2010.12.019","article-title":"The CCAAT\/enhancer (C\/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation","volume":"54","author":"Tsukada","year":"2011","journal-title":"Cytokine"},{"key":"B36","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1182\/blood.V80.7.1725.1725","article-title":"A novel temporal expression pattern of three C\/EBP family members in differentiating myelomonocytic cells","volume":"80","author":"Scott","year":"1992","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"29279","DOI":"10.1074\/jbc.273.45.29279","article-title":"The role of C\/EBP isoforms in the control of inflammatory and native immunity functions","volume":"273","author":"Poli","year":"1998","journal-title":"J Biol Chem"},{"issue":"11","key":"B38","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1128\/MCB.21.11.3789-3806.2001","article-title":"c-Myc is a critical target for C\/EBPalpha in granulopoiesis","volume":"21","author":"Johansen","year":"2001","journal-title":"Mol Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1634\/stemcells.19-2-125","article-title":"The role of C\/EBPepsilon in the terminal stages of granulocyte differentiation","volume":"19","author":"Lekstrom-Himes","year":"2001","journal-title":"Stem Cells"},{"key":"B40","doi-asserted-by":"publisher","first-page":"52651","DOI":"10.1074\/jbc.M307077200","article-title":"Restoration of C\/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation","volume":"278","author":"Tavor","year":"2003","journal-title":"J Biol Chem"},{"key":"B41","first-page":"25","article-title":"C\/EBP\u00ce\u00b2: a candidate for a major player in vitamin D-induced monocytic differentiation of human leukemia cells","volume-title":"Vitamin D: New Research","author":"Marcinkowska","year":"2006"},{"key":"B42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bcmd.2007.06.010","article-title":"C\/EBPalpha induces PU.1 and interacts with AP-1 and NF-kappaB to regulate myeloid development","volume":"39","author":"Friedman","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.20032226","article-title":"PML-RARA-RXR oligomers mediate retinoid and rexinoid\/cAMP cross-talk in acute promyelocytic leukemia cell differentiation","volume":"199","author":"Kamashev","year":"2004","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccr.2007.06.004","article-title":"RXR is an essential component of the oncogenic PML\/RARA complex in vivo","volume":"12","author":"Zhu","year":"2007","journal-title":"Cancer Cell"},{"key":"B45","first-page":"7050","article-title":"AML-associated translocation products block vitamin D3-induced differentiation by sequestering the vitamin D3 receptor","volume":"62","author":"Puccetti","year":"2002","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/sj.cdd.4400673","article-title":"Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases","volume":"7","author":"Gianni","year":"2000","journal-title":"Cell Death Differ"},{"key":"B47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/sj.leu.2401650","article-title":"Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia","volume":"14","author":"Cai","year":"2000","journal-title":"Leukemia"},{"key":"B48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/shem.2001.20863","article-title":"Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies","volume":"38","author":"Chen","year":"2001","journal-title":"Semin Hematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0163-7258(97)00090-9","article-title":"Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis","volume":"76","author":"Chen","year":"1997","journal-title":"Pharmacol Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"49504","DOI":"10.1074\/jbc.M207836200","article-title":"Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1083\/jcb.201112044","article-title":"The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies","volume":"198","author":"de Th\u00c3\u00a9","year":"2012","journal-title":"J Cell Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"14807","DOI":"10.1073\/pnas.96.26.14807","article-title":"Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins","volume":"96","author":"Zhu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1084\/jem.193.12.1361","article-title":"Role of promyelocytic leukemia (PML) sumoylation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML\/retinoic acid receptor alpha degradation","volume":"193","author":"Lallemand-Breitenbach","year":"2001","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ccr.2010.06.003","article-title":"PML\/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3","volume":"18","author":"Jeanne","year":"2010","journal-title":"Cancer Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1182\/blood-2010-01-261040","article-title":"Autophagy contributes to therapy-induced degradation of the PML\/RARA oncoprotein","volume":"116","author":"Isakson","year":"2010","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.0954-6820.1957.tb00124.x","article-title":"Acute promyelocytic leukemia","volume":"159","author":"Hillestad","year":"1957","journal-title":"Acta Med Scand"},{"key":"B58","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM199105163242002","article-title":"Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)","volume":"324","author":"Warrell","year":"1991","journal-title":"N Engl J Med"},{"key":"B59","first-page":"1014","article-title":"Molecular remission in PML\/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell\u00e2\u20ac\u2122Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups","volume":"90","author":"Mandelli","year":"1997","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/sj.leu.2402106","article-title":"Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage","volume":"15","author":"Shen","year":"2001","journal-title":"Leukemia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-014-0206-5","article-title":"What is the standard regimen for patients with acute promyelocytic leukemia?","author":"Lo-Coco","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1182\/blood-2007-02-075804","article-title":"AML1\/ETO, a promiscuous fusion oncoprotein","volume":"109","author":"Petrie","year":"2007","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2006.10.010","article-title":"Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation","volume":"251","author":"Elagib","year":"2007","journal-title":"Cancer Lett"},{"key":"B65","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.1074\/jbc.M010582200","article-title":"Multiple regions of ETO cooperate in transcriptional repression","volume":"276","author":"Hildebrand","year":"2001","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1182\/blood-2006-09-045781","article-title":"Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia","volume":"109","author":"Fazi","year":"2007","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1182\/blood-2013-03-488114","article-title":"Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors","volume":"123","author":"Bots","year":"2014","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/35901","article-title":"Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia","volume":"391","author":"Grignani","year":"1998","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1038\/sj.onc.1204336","article-title":"Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?","volume":"20","author":"Minucci","year":"2001","journal-title":"Oncogene"},{"key":"B70","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1158\/1535-7163.1249.3.10","article-title":"Peroxisome proliferator-activated receptor \u00ce\u00b3 and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias","volume":"3","author":"Konopleva","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"B71","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc1254","article-title":"Peroxisome-proliferator-activated receptors and cancers: complex stories","volume":"4","author":"Michalik","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrg1427","article-title":"WNT and beta-catenin signalling: diseases and therapies","volume":"5","author":"Moon","year":"2004","journal-title":"Nat Rev Genet"},{"key":"B73","first-page":"1027","article-title":"Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids","volume":"15","author":"Asou","year":"1999","journal-title":"Int J Oncol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(00)81575-5","article-title":"PPAR\u00ce\u00b3 promotes monocyte\/macrophage differentiation and uptake of oxidized LDL","volume":"93","author":"Tontonoz","year":"1998","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1357-2725(96)00101-X","article-title":"Retinoid X receptors","volume":"29","author":"Rowe","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1158\/1078-0432.CCR-07-5185","article-title":"A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia","volume":"14","author":"Tsai","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-009-0954-6","article-title":"Global vitamin D status and determinants of hypovitaminosis D","volume":"20","author":"Mithal","year":"2009","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"B79","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1007\/BF00638238","article-title":"Vitamin D3 and skin diseases","volume":"284","author":"Kragballe","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1172\/JCI200212392","article-title":"Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice","volume":"109","author":"O\u00e2\u20ac\u2122Kelly","year":"2002","journal-title":"J Clin Invest"},{"key":"B81","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts","volume":"97","author":"van Etten","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/10428190701757827","article-title":"Vitamin D compounds and myelodysplastic syndrome","volume":"49","author":"Okamoto","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"B83","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1358\/dot.2010.46.5.1473264","article-title":"Vitamin D analogue-based therapies for psoriasis","volume":"46","author":"O\u00e2\u20ac\u2122Neill","year":"2010","journal-title":"Drugs Today"},{"key":"B84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0960-0760(02)00277-7","article-title":"Impact of the vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer","volume":"83","author":"Welsh","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.mam.2008.04.001","article-title":"Vitamin D analogs: therapeutic applications and mechanisms for selectivity","volume":"29","author":"Brown","year":"2008","journal-title":"Mol Aspects Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7150\/jca.1.101","article-title":"Vitamin D in combination cancer treatment","volume":"1","author":"Ma","year":"2010","journal-title":"J Cancer"},{"issue":"8405","key":"B87","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(84)92676-X","article-title":"Treatment of advanced myelodysplastic syndrome with alfacalcidol","volume":"2","author":"Mehta","year":"1984","journal-title":"Lancet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0006-291X(81)91628-4","article-title":"1 Alpha,25-dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells","volume":"102","author":"Miyaura","year":"1981","journal-title":"Biochem Biophys Res Commun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2011.10.026","article-title":"Application of vitamin D and derivatives in hematological malignancies","volume":"319","author":"Kim","year":"2012","journal-title":"Cancer Lett"},{"key":"B90","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jsbmb.2011.04.006","article-title":"Structure-function analysis of vitamin D2 analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation","volume":"126","author":"Baurska","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1210\/mend-3-4-635","article-title":"Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression","volume":"3","author":"McDonnell","year":"1989","journal-title":"Mol Endocrinol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1006\/bbrc.1994.2081","article-title":"Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter","volume":"202","author":"Kahlen","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"B93","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jmb.2005.04.057","article-title":"Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-dihydroxyvitamin D3","volume":"350","author":"Vaisanen","year":"2005","journal-title":"J Mol Biol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"7078","DOI":"10.1038\/sj.onc.1209697","article-title":"Induction of kinase suppressor of RAS-1(KSR-1) gene by 1,25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 50-flanking region","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/jcb.20780","article-title":"Functional role of VDR in the activation of p27Kip1 by the VDR\/Sp1 complex","volume":"98","author":"Cheng","year":"2006","journal-title":"J Cell Biochem"},{"issue":"7","key":"B96","doi-asserted-by":"publisher","first-page":"e71042","DOI":"10.1371\/journal.pone.0071042","article-title":"Primary vitamin D target genes allow a categorization of possible benefits of vitamin D3 supplementation","volume":"8","author":"Carlberg","year":"2013","journal-title":"PLoS One"},{"key":"B97","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/bbrc.1997.7832","article-title":"1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells","volume":"241","author":"Marcinkowska","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"B98","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/jcb.20787","article-title":"1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS\/RAF\/ERK-MAP kinase signalling pathway","volume":"98","author":"Hughes","year":"2006","journal-title":"J Cell Biochem"},{"key":"B99","first-page":"3507","article-title":"Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol","volume":"18","author":"Marcinkowska","year":"1998","journal-title":"Anticancer Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1084\/jem.190.11.1583","article-title":"1Alpha,25-dihydroxyvitamin D3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex","volume":"190","author":"Hmama","year":"1999","journal-title":"J Exp Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7150\/jca.1.101","article-title":"Vitamin D and acute myeloid leukemia","volume":"3","author":"Ma","year":"2010","journal-title":"J Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PPO.0b013e3181c51ee6","article-title":"Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy","volume":"16","author":"Trump","year":"2010","journal-title":"Cancer J"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.yexcr.2006.03.003","article-title":"Regulation of C\/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3","volume":"312","author":"Marcinkowska","year":"2006","journal-title":"Exp Cell Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1006\/excr.1999.4660","article-title":"Monocytically differentiating HL60 cells proliferate rapidly before they mature","volume":"253","author":"Brown","year":"1999","journal-title":"Exp Cell Res"},{"key":"B105","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood.V93.8.2721","article-title":"Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression","volume":"93","author":"Rots","year":"1999","journal-title":"Blood"},{"key":"B106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2220\/biomedres.27.89","article-title":"1,25-Dihydroxyvitamin D3 suppresses exportin expression in human promyelocytic leukemia HL-60 cells","volume":"27","author":"Suzuki","year":"2006","journal-title":"Biomed Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1247\/csf.30.1","article-title":"1,25-Dihydroxyvitamin D3 suppresses gene expression of eukaryotic translation initiation factor 2 in human promyelocytic leukemia HL-60 cells","volume":"30","author":"Suzuki","year":"2005","journal-title":"Cell Struct Funct"},{"key":"B108","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1600-0609.1988.tb00855.x","article-title":"Therapeutic effects of low-dose cytosine arabinoside, alpha-interferon, 1 alpha-hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes","volume":"40","author":"Hellstr\u00c3\u00b6m","year":"1988","journal-title":"Eur J Haematol"},{"key":"B109","first-page":"1183","article-title":"Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]","volume":"15","author":"Irino","year":"1988","journal-title":"Gan To Kagaku Ryoho"},{"key":"B110","first-page":"1026","article-title":"Successful treatment of a patient with acute myeloid leukemia with 1 alpha(OH)D3","volume":"51","author":"Nakayama","year":"1988","journal-title":"Nihon Ketsueki Gakkai Zasshi"},{"key":"B111","first-page":"1","article-title":"Therapeutic effectiveness of vitamin D3 in patients with myelodysplastic syndromes, leukemias and myeloproliferative disorders","volume":"30","author":"Takahashi","year":"1989","journal-title":"Rinsho Ketsueki"},{"key":"B112","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1600-0609.1990.tb00470.x","article-title":"Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG)","volume":"45","author":"Hellstr\u00c3\u00b6m","year":"1990","journal-title":"Eur J Haematol"},{"key":"B113","first-page":"200","article-title":"Low-dose ARA-C and 1(OH)D3 administration in acute non lymphoid leukemia: pilot study","volume":"76","author":"Petrini","year":"1991","journal-title":"Haematologica"},{"key":"B114","first-page":"467","article-title":"Synergistic effects of alpha interferon and 1,25 dihydroxyvitamin D3: preliminary evidence suggesting that interferon induces expression of the vitamin receptor","volume":"76","author":"Petrini","year":"1991","journal-title":"Haematologica"},{"key":"B115","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ajh.2830410307","article-title":"Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol","volume":"41","author":"Slapak","year":"1992","journal-title":"Am J Hematol"},{"key":"B116","first-page":"619","article-title":"Differentiating agents + low-dose chemotherapy in the management of old\/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome","volume":"89","author":"Ferrero","year":"2004","journal-title":"Haematologica"},{"key":"B117","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1155\/2012\/125814","article-title":"Clinical experience using vitamin D and analogs in the treatment of myelodysplasia and acute myeloid leukemia: a review of the literature","volume":"125814","author":"Harrison","year":"2012","journal-title":"Leuk Res Treatment"},{"key":"B118","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ecl.2010.02.003","article-title":"Vitamin D analogs","volume":"39","author":"Jones","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B119","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/ki.2010.387","article-title":"New vitamin D analogs and changing therapeutic paradigms","volume":"79","author":"Cunningham","year":"2011","journal-title":"Kidney Int"},{"key":"B120","first-page":"2647","article-title":"Calcitriol in the treatment of prostate cancer","volume":"26","author":"Beer","year":"2006","journal-title":"Anticancer Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00280-007-0666-6","article-title":"Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model","volume":"62","author":"Wietrzyk","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0090-4295(01)01254-7","article-title":"Rationale for combination ketoconazole\/vitamin D treatment of prostate cancer","volume":"58","author":"Peehl","year":"2001","journal-title":"Urology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1097\/00005392-200210010-00089","article-title":"Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells","volume":"168","author":"Peehl","year":"2002","journal-title":"J Urol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1210\/en.2009-1156","article-title":"CYP24A1 inhibition enhances the antitumor activity of calcitriol","volume":"151","author":"Muindi","year":"2010","journal-title":"Endocrinology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00280-005-0059-7","article-title":"Expression of VDR and CYP24A1 mRNA in human tumors","volume":"57","author":"Anderson","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jsbmb.2010.03.080","article-title":"CYP24A1 splice variants \u00e2\u20ac\u201c implications for the antitumorigenic actions of 1,25-(OH)2D3 in colorectal cancer","volume":"121","author":"Horv\u00c3\u00a1th","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/ijc.28143","article-title":"Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer","volume":"133","author":"H\u00c3\u00b6baus","year":"2013","journal-title":"Int J Cancer"},{"key":"B128","first-page":"1339","article-title":"A phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy","volume":"5","author":"Smith","year":"1999","journal-title":"Clin Cancer Res"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/1097-0142(20010615)91:122431::AID-CNCR12783.0.CO;2-3","article-title":"A phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation","volume":"91","author":"Beer","year":"2001","journal-title":"Cancer"},{"key":"B130","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1067\/mcp.2002.129305","article-title":"Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel","volume":"72","author":"Muindi","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"B131","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"B132","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/asheducation-2008.1.1","article-title":"Acute myeloid leukemia: the challenge of capturing disease variety","volume":"2008","author":"Lowenberg","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B134","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/MOH.0b013e32835d821c","article-title":"The evolving molecular genetic landscape in acute myeloid leukaemia","volume":"20","author":"Sanders","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"B135","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12185-012-1123-9","article-title":"Molecular markers in acute myeloid leukaemia","volume":"96","author":"Kuhnl","year":"2012","journal-title":"Int J Hematol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3324\/haematol.11007","article-title":"Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias","volume":"92","author":"Falini","year":"2007","journal-title":"Haematologica"},{"key":"B137","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/pro.2240","article-title":"Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization","volume":"22","author":"Federici","year":"2013","journal-title":"Protein Sci"},{"key":"B138","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0268-960X(03)00024-9","article-title":"Receptor tyrosine kinases in normal and malignant haematopoiesis","volume":"17","author":"Reilly","year":"2003","journal-title":"Blood Rev"},{"key":"B139","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"B140","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.leukres.2009.10.004","article-title":"Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations","volume":"34","author":"Gocek","year":"2010","journal-title":"Leuk Res"},{"key":"B141","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.leukres.2014.03.009","article-title":"Monocytic differentiation induced by side-chain modified analogs of vitamin D in ex vivo cells from patients with acute myeloid leukemia","volume":"38","author":"Baurska","year":"2014","journal-title":"Leuk Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.leu.2402740","article-title":"FLT3 mutations in acute myeloid leukemia cell lines","volume":"17","author":"Quentmeier","year":"2003","journal-title":"Leukemia"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e91752","DOI":"10.1371\/journal.pone.0091752","article-title":"NADPH-cytochrome p450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells","volume":"9","author":"Gocek","year":"2014","journal-title":"PLoS One"},{"key":"B144","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0960-0760(98)00065-X","article-title":"Cell differentiating and anti-proliferative activity of side-chain modified analogues of 1,25-dihydroxyvitamin D3","volume":"67","author":"Marcinkowska","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B145","first-page":"3570","article-title":"Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells","volume":"56","author":"Elstner","year":"1996","journal-title":"Cancer Res"},{"key":"B146","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1172\/JCI119164","article-title":"Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid","volume":"99","author":"Elstner","year":"1997","journal-title":"J Clin Invest"},{"key":"B147","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0145-2126(93)90108-W","article-title":"Interaction of retinoic acid and vitamin D3 analogs on HL-60 myeloid leukemic cells","volume":"17","author":"Dor\u00c3\u00a9","year":"1993","journal-title":"Leuk Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/(SICI)1097-4652(199901)178:1109::AID-JCP143.0.CO;2-X","article-title":"Transforming growth factor-beta1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids","volume":"178","author":"Defacque","year":"1999","journal-title":"J Cell Physiol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1172\/JCI112593","article-title":"Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells","volume":"78","author":"Munker","year":"1986","journal-title":"J Clin Invest"},{"key":"B150","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jsbmb.2012.07.001","article-title":"Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation","volume":"132","author":"Gocek","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1172\/JCI110450","article-title":"Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells","volume":"69","author":"Douer","year":"1982","journal-title":"J Clin Invest"},{"key":"B152","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1073\/pnas.85.10.3294","article-title":"Cloning and expression of full-length cDNA encoding human vitamin D receptor","volume":"85","author":"Baker","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1210\/mend.11.8.9951","article-title":"Structural organization of the human vitamin D receptor chromosomal gene and its promoter","volume":"11","author":"Miyamoto","year":"1997","journal-title":"Mol Endocrinol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1210\/me.14.3.401","article-title":"The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB","volume":"14","author":"Jurutka","year":"2000","journal-title":"Mol Endocrinol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/eji.200636043","article-title":"The vitamin D receptor gene FokI polymorphism: functional impact on the immune system","volume":"37","author":"van Etten","year":"2007","journal-title":"Eur J Immunol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"10529","DOI":"10.1073\/pnas.95.18.10529","article-title":"Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts","volume":"95","author":"Crofts","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1210\/me.15.9.1599","article-title":"Novel N-terminal variant of human VDR","volume":"15","author":"Sunn","year":"2001","journal-title":"Mol Endocrinol"},{"issue":"9\u00e2\u20ac\u201c90","key":"B158","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jsbmb.2004.03.078","article-title":"Vitamin D receptor B1 and exon 1d: functional and evolutionary analysis","volume":"8","author":"Gardiner","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1359\/jbmr.1999.14.2.240","article-title":"The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine","volume":"14","author":"Yamamoto","year":"1999","journal-title":"J Bone Miner Res"},{"key":"B160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1152\/physiolgenomics.00046.2001","article-title":"Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter","volume":"7","author":"Lee","year":"2001","journal-title":"Physiol Genomics"},{"key":"B161","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1210\/endo.141.8.7618","article-title":"Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene","volume":"141","author":"Byrne","year":"2000","journal-title":"Endocrinology"},{"key":"B162","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mce.2004.11.001","article-title":"Regulation of the human Vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites","volume":"230","author":"Wietzke","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S1097-2765(02)00781-5","article-title":"Looping and interaction between hypersensitive sites in the active beta-globin locus","volume":"10","author":"Tolhuis","year":"2002","journal-title":"Mol Cell"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T17:33:48Z","timestamp":1689269628000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2014.00125\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,27]]},"references-count":163,"URL":"https:\/\/doi.org\/10.3389\/fonc.2014.00125","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,27]]}}}